These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17727618)

  • 1. Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.
    Sarov B; Novack L; Beer N; Safi J; Soliman H; Pliskin JS; Litvak E; Yaari A; Shinar E
    Transfus Med; 2007 Dec; 17(6):479-87. PubMed ID: 17727618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
    Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
    Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pooled screening for anti-HCV in two blood services set-ups.
    Novack L; Shinar E; Safi J; Soliman H; Yaari A; Galai N; Pliskin JS; Sarov B
    Trop Med Int Health; 2007 Mar; 12(3):415-21. PubMed ID: 17313513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations.
    Novack L; Sarov B; Goldman-Levi R; Yahalom V; Safi J; Soliman H; Orgel M; Yaari A; Galai N; Pliskin JS; Shinar E
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):787-92. PubMed ID: 18486172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.
    Tobler LH; Stramer SL; Lee SR; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch MP
    Vox Sang; 2005 Nov; 89(4):201-7. PubMed ID: 16262752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.
    García Z; Taylor L; Ruano A; Pavón L; Ayerdis E; Luftig RB; Visoná KA
    J Med Virol; 1996 Jul; 49(3):218-22. PubMed ID: 8818968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
    Roth WK; Weber M; Seifried E
    Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?
    Pawlotsky JM; Lonjon I; Hezode C; Raynard B; Darthuy F; Remire J; Soussy CJ; Dhumeaux D
    Hepatology; 1998 Jun; 27(6):1700-2. PubMed ID: 9620345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy and cost-benefit of pooled versus singleton screening blood donations for anti-HIV: impact on different blood bank set-ups.
    Novack L; Pliskin JS; Shinar E; Safi J; Sarov B
    Trop Doct; 2006 Oct; 36(4):236-9. PubMed ID: 17034705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C core antigen in Polish blood donors.
    Letowska M; Brojer E; Mikulska M; Gronowska A; Rosiek A
    Transfusion; 2004 Jul; 44(7):1067-71. PubMed ID: 15225249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation on the use of detection of hepatitis C core antigen for screening blood donor].
    Wang FC; Shi ZY; Cai J; Su J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):389-90. PubMed ID: 18322613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
    Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
    Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
    Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.